GE South Asia & Wipro appoint Milan Rao as president & CEO of healthcare business

GE South Asia and Wipro have appointed Milan Rao to lead GE’s healthcare business as president and CEO, GE Healthcare South Asia and managing director, Wipro GE Healthcare.

Effective May 1, 2015, he replaces Terri Bresenham, who has been leading GE Healthcare’s South Asia business since September 2011. Milan will report to Azim Premji, chairman, Wipro Ltd and Banmali Agrawala, president and CEO, GE South Asia.

Rao will build on Wipro GE’s expansion plans and continue to strengthen the company’s ‘In India, for India’ proposition of innovating disruptive technology and business solutions to enhance access to high quality, affordable healthcare solutions.

Terri, a 25-year veteran at GE, will move to a global role. In the last three years, she has led GE Healthcare to launch winning initiatives like skill building programmes, industry partnerships and breakthrough products such as discovery IQ and revolution ACTs.

“Rao  will take GE’s mission of a Healthier India forward through development of disruptive technologies and business models in India, for India, said Banmali Agrawala, president and CEO, GE South Asia.

“Wipro and GE have enjoyed a strong and enduring partnership lasting over 25 years that has made an indelible mark on India’s healthcare industry. I am confident Rao will further strengthen this relationship and give an added impetus to our mission to build a healthier India,” said Azim Premji, chairman, Wipro Ltd and non-executive chairman, Wipro Enterprises Ltd.

Takeda - Wipro strtegic partnership

Wipro Ltd., the information technology leader has entered into a  strategic partnership with Takeda Pharmaceutical Company Ltd., the largest pharmaceutical company in Japan and one of the global leaders of the industry.

The  strategic partnership will build advanced value in Takeda's operations by consolidating IT platforms across the organisation. As a strategic partner, Wipro will build and maintain an “as-a-service” global platform for Takeda that will drive synergies across its global entities through standardisation of IT architecture.

 Wipro will be primary provider of IT Infrastructure management services covering Takeda’s entities across the world, touching 30,000 users in 16 different languages, operating out of data centers in Asia, Europe and America.



According to Sangita Singh, chief executive Healthcare and Life Science Business Unit at Wipro, the partnership with Takeda is for a business transformation.  Wipro is leveraging its experience in enabling global pharma companies to achieve a leaner & standardized IT workplace and implement newer business models that put patient at the core. We look forward to collaboratively partnering with the Takeda team in enabling this unique platform across its global operations.